Consumer Recalls Daily — 2026-05-26

TITLE: Recall Digest 2026-05-26: Can-Am ATVs cite death risk; Petzl harnesses, Generac washers, kid towers; Ajanta nitrosamines lead FDA actions

---

CPSC — Consumer Products

Lead: Death-risk hazards

• BRP's Can-Am ATV recall (#26482) is the standout: a malfunctioning speed-limiter can trigger unexpected acceleration, with CPSC explicitly flagging risk of death from crash. Consumers are told to stop using Speed Limiter Mode immediately pending a fix.
• Generac Power Systems (#26494) is expanding its earlier recall of Generac and DR Power electric-start pressure washers to additional models — the start/stop button can self-start the gas engine, posing a carbon-monoxide death risk in enclosed spaces.
• Petzl America issued two simultaneous harness recalls: #26488 covers ASTRO BOD FAST, ASTRO SIT FAST and CANYON GUIDE units whose D-rings can release, and #26487 covers SIMBA and SWAN EASYFIT harnesses missing rivets in the FAST LT PIN-LOCK buckles — both fall hazards for work-at-height and canyoneering users.
• Minka Lighting's Bardon-series pendants (#26479) can detach from the downrod during installation, an impact hazard the agency rates as potentially fatal.

Children's products — recurring failure modes

The week's largest category by volume is child-hazard violations, dominated by button-cell battery access and toy-standard failures:

• Lithium coin batteries from LiCB / Guangzhou Lichengbei (#26484), sold on Amazon, lack the child-resistant packaging required under Reese's Law; EEMB USA battery pouches (#26465) were recalled the prior week for the same statutory violation.
• Toys giving children direct access to button cells: Missry Associates' Misco Sports badminton sets (#26483) (shuttlecocks) and ZMC Group's light-up toys (#26466).
• Cosyland children's tower stools (#26493) can collapse and have torso-sized openings — entrapment plus fall risk — while Guidecraft standing towers (#26490) can have their internal platform loosen and detach.
• Tiyol pull-string teething toys sold on Amazon by ZW Creations (#26481) have over-length silicone strings that can lodge in the throat; Rainbow Wall xylophone toys from Justforjoyful (#26472) have a spherical drumstick end that fails the small-parts standard.
• Two bike-helmet recalls cite positional-stability and certification failures under the mandatory standard: Favoto helmets on Amazon (#26467) and multi-purpose helmets sold on Temu by Foubeaka and Geniuss (#26470).
• Allura Imports' bobcat-logo youth sweatshirts (#26477) violate the children's upper-outerwear drawstring rule (strangulation), and UHOMEPRO 5-drawer dressers (#26448) fail the clothing-storage-unit stability standard (tip-over/entrapment).
• Natural Pigments' Rublev Colours gum turpentine and mineral spirits (#26469) were shipped without the child-resistant packaging required by the Poison Prevention Packaging Act.

Adult and home hazards

• Amazon Basics 55-lb adjustable dumbbells (#26486): plates can fail to engage and dislodge mid-lift, an impact hazard prompting a stop-use notice from Amazon itself.
• ZWILLING J.A. Henckels electric water kettles (#26489) can have the handle separate from the body, spilling boiling water — burn hazard.
• Agio Menlo woven patio swings (#26485), sold at Costco and imported by World Bright International, can have the seat detach from the frame mid-use (fall).
• Analemma water bottles imported by New Earth Technologies (#26475) have inner glass liners that can shatter, posing laceration and ingestion risks.
• Superbobi pool drain covers from Remy&shop (#26480) violate the Virginia Graeme Baker Pool & Spa Safety Act — entrapment/drowning.
• Svnntaa adult portable bed rails sold on Amazon by Eokeanon (#26468) fail the mandatory adult bed-rail standard (entrapment/asphyxiation).
• EVLWZL and Gunugu mattresses (#26478) fail the mandatory mattress-flammability standard outright.

Amazon and Temu marketplaces are again the common distribution channel for the small-importer violations above — at least eight of this week's CPSC actions name one of those platforms in the product chain.

FDA — Drugs and Medical Products

All ten FDA actions this digest are Class II (temporary or medically reversible adverse health consequences); no Class I drug recalls were posted. Nitrosamine impurities and sterility lapses dominate.

Nitrosamines and impurity failures

• Ajanta Pharma Ltd. initiated parallel recalls of duloxetine delayed-release capsules — 20 mg (D-0516-2026, NDC 27241-097-06) and 30 mg (D-0514-2026, NDC 27241-098-03/-09/-10) — after N-nitroso-duloxetine exceeded the FDA-recommended 0.83 ppm limit at 12- and 18-month stability intervals. Marketed via Ajanta Pharma USA (Bridgewater, NJ).
• Ascend Laboratories' metoprolol succinate ER 25 mg (D-0547-2026, NDC 67877-590-01), made by Alkem in India, failed dissolution specifications.
• Rising Pharma / J.B. Chemicals enalapril maleate 20 mg, 1,000-count bottles (D-0520-2026) failed organic-impurities testing.
• Acella Pharmaceuticals' naproxen oral suspension 125 mg/5 mL (D-0523-2026, NDC 42192-619-16) was recalled for lead and lithium contamination above specification — notable because it is a pediatric-friendly liquid formulation.
• Endo USA's buprenorphine HCl injection 0.3 mg/mL (D-0527-2026, NDC 42023-179-05) contains particulate matter identified as buprenorphine free base.

Sterility and compounding

• CareFusion 213 (a BD subsidiary) recalled two BD PurPrep povidone-iodine/IPA surgical prep configurations — 10.5 mL applicators (D-0518-2026) and 26 mL applicators, NDC 54365-014-42 (D-0517-2026) — for potential contamination undermining sterility assurance.
• OASIS Medical's Oasis Tears PF preservative-free eye drops, 10 mL (D-0525-2026, NDC 42126-6400-1), made in France by Excelvision, were pulled out of caution after FDA inspection observations at the manufacturer.
• Central Admixture Pharmacy Services (CAPS) Los Angeles recalled a patient-specific TPN bag, Rx# 11-4909703-0-1 (D-0524-2026) that was compounded without the insulin its label indicated — a formulation error rather than a contamination event, but one with obvious downstream patient impact.